Current issues in antiplatelet therapy for stroke prevention: The importance of stroke subtypes and differences between stroke and MI patients

Journal of Neurology

Volumn 257, Issue 11, 2010, Pages 1788-1797

  Kirshner, H S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiplatelet; Hypertension; Myocardial infarction; Stroke; Transient ischaemic attack

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN ETEXILATE; DIPYRIDAMOLE; IRBESARTAN; WARFARIN;

ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; ATHEROSCLEROSIS; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ETHNICITY; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMOBILIZATION; INFECTION; INTERNATIONAL NORMALIZED RATIO; LACUNAR STROKE; LARGE VESSEL STROKE; MONOTHERAPY; OBESITY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SMOKING; SMOKING CESSATION; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING;

HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION; STROKE;

EID: 78549279437     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5667-4     Document Type: Review

References (76)

1. American Heart Association/American Stroke Association. Heart Disease and Stroke Statistics (2009) Update at-a-glance. http://www.americanheart.org/ downloadable/heart/1240250946756LS-1982%20Heart%20and%20Stroke%20Update.042009. pdf. Accessed 28 Jul 2009
2. T Truelsen B Piechowski-Jozwiak R Bonita, et al. 2006 Stroke incidence and prevalence in Europe: a review of available data Eur J Neurol 13 581 598 1:STN:280:DC%2BD28zotFahuw%3D%3D 10.1111/j.1468-1331.2006.01138.x 16796582 (Pubitemid 43873630)
3. HS Kirshner 2009 Differentiating ischemic stroke subtypes: risk factors and secondary prevention J Neurol Sci 279 1 8 10.1016/j.jns.2008.12.012 19185319
4. P Amarenco J Bogousslavsky LR Caplan GA Donnan MG Hennerici 2009 Classification of stroke subtypes Cerebrovasc Dis 27 493 501 1:STN:280:DC%2BD1Mzht1ajsg%3D%3D 10.1159/000210432 19342825
5. C Jackson C Sudlow 2005 Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts Stroke 36 891 901 10.1161/01.STR.0000157949.34986.30 15761206
6. HP Adams Jr BH Bendixen LJ Kappelle J Biller BB Love DL Gordon EE Marsh 3rd 1993 Classification of subtype of acute ischemic stroke. Definition for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 35 41 7678184
7. M Fisher 2008 Stroke and TIA: epidemiology, risk factors, and the need for early intervention Am J Managed Care 14 S204 S211
8. AJ Grau C Weimar F Buggle A Heinrich M Goertler S Neumaier J Glahn T Brandt W Hacke HC Diener 2001 Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank Stroke 32 2559 2566 1:STN:280:DC%2BD3MnktFegug%3D%3D 10.1161/hs1101.098524 11692017
9. NU Weir 2008 An update on cardioembolic stroke Postgrad Med J 84 133 142 1:STN:280:DC%2BD1c3htlCitQ%3D%3D 10.1136/pgmj.2007.066563 18372484 (Pubitemid 351506209)
10. HS Kirshner J Biller AS Callahan 2005 Long-term therapy to prevent stroke J Am Board Fam Prac 18 528 540 10.3122/jabfm.18.6.528
11. T Leoo A Lindgren J Petersson M von Arbin 2008 Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study Cerebrovasc Dis 25 254 260 1:STN:280: DC%2BD1c3gsleisw%3D%3D 10.1159/000113864 18216468 (Pubitemid 351450429)
12. H White B Boden-Albala C Wang MS Elkind T Rundek CB Wright RL Sacco 2005 Ischemic stroke subtype incidence among whites, blacks, and Hispanics. The Northern Manhattan Study Circulation 111 1327 1331 10.1161/01.CIR.0000157736. 19739.D0 15769776 (Pubitemid 40389099)
13. A Taqui AK Kamal 2007 Stroke in Asians Pak J Neurol Sci 2 14 17
14. RL Sacco R Adams G Albers MJ Alberts O Benavente K Furie LB Goldstein P Gorelick J Halperin R Harbaugh SC Johnston I Katzan M Kelly-Hayes EJ Kenton M Marks LH Schwamm T Tomsick American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology 2006 Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline Stroke 37 577 617 10.1161/01.STR.0000199147.30016.74 16432246
15. T Hillen C Coshall K Tilling AG Rudd R McGovern CD Wolfe South London Stroke Register 2003 Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London register Stroke 34 1457 1463 10.1161/01.STR.0000072985.24967.7F 12750544 (Pubitemid 36693517)
16. E Touzé J Coste M Voicu J Kansao R Masmoudi B Doumenc P Durieux JL Mas 2008 Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention. IMplementaion of Prevention After a Cerebrovascular event (IMPACT) study Stroke 39 1834 1843 10.1161/STROKEAHA.107. 503094 18388344
17. PL Kolominsky-Rabas M Weber O Gefellar B Neundoerfer PU Heuschmann 2001 Epidemiology of ischemic subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study Stroke 32 2735 2740 1:STN:280:DC%2BD3Mnptlyhug%3D%3D 10.1161/hs1201.100209 11739965
18. T Ohira E Shahar LE Chambless WD Rosamond TH Mosley Jr AR Folsom 2006 Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities Study Stroke 37 2493 2498 1:CAS:528:DC%2BD28Xps1Ggsbk%3D 10.1161/01.STR.0000239694.19359.88 16931783 (Pubitemid 44454667)
19. T Mannami H Iso S Baba S Sasaki K Okada M Konishi S Tsugane Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Group 2004 Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC Study Cohort I Stroke 35 1248 1253 10.1161/01.STR.0000128794.30660.e8 15118170 (Pubitemid 38697436)
20. JA Ambrose RS Barua 2004 The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 1731 1737 1:CAS:528:DC%2BD2cXktVCms7k%3D 10.1016/j.jacc.2003.12.047 15145091 (Pubitemid 38622506)
21. SH Suk B Boden-Albala JF Cheun, et al. 2003 Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study Stroke 34 1586 1592 10.1161/01.STR.0000075294.98582.2F 12775882 (Pubitemid 36842606)
22. S Ruland E Hung D Richardson S Misra PB Gorelick African American Antiplatelet Stroke Prevention Study Investigators 2005 Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors Arch Neurol 62 386 390 10.1001/archneur.62.3.386 15767503 (Pubitemid 40349473)
23. L Dauchet P Amouyel J Dallongeville 2005 Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies Neurology 65 1193 1197 10.1212/01.wnl.0000180600.09719.53 16247045 (Pubitemid 41508210)
24. H Iso K Rexrode M Stampfer JE Manson GA Colditz FE Speizer CH Hennekens WC Willett 2001 Intake of fish and omega-3 fatty acids and risk of stroke in women JAMA 285 304 312 1:STN:280:DC%2BD3M7kslamsQ%3D%3D 10.1001/jama.285.3.304 11176840
25. K He E Rimm A Merchant BA Rosner MJ Stampfer WC Willett A Ascherio 2002 Fish consumption and risk of stroke in men JAMA 288 3130 3136 1:CAS:528:DC%2BD3sXhslWm 10.1001/jama.288.24.3130 12495393 (Pubitemid 36014130)
26. JK Virtanen DS Siscovick WT Longstreth Jr LH Kuller D Mozaffarian 2008 Fish consumption and risk of subclinical brain abnormalities on MRI in older adults Neurology 71 439 446 1:CAS:528:DC%2BD1cXptFSltb4%3D 10.1212/01.wnl. 0000324414.12665.b0 18678827
27. SD Poppitt AH Colin FE Lithander KM Silvers RB Lin J Croft Y Ratnasabapathy RA Gibson CS Anderson 2009 Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke Stroke 40 3485 3492 1:CAS:528:DC%2BD1MXhtlWgu7bM 10.1161/STROKEAHA.109.555136 19745175
28. M Endres K Gertz U Lindauer J Katchanov J Schultze H Schröck G Nickenig W Kuschinsky U Dirnagl U Laufs 2003 Mechanisms of stroke protection by physical activity Ann Neurol 54 582 590 10.1002/ana.10722 14595647 (Pubitemid 37346064)
29. AJ Grau C Barth B Geletneky P Ling F Palm C Lichy H Becher F Buggle 2009 Association between recent sports activity, sports activity in young adulthood, and stroke Stroke 40 426 431 10.1161/STROKEAHA.108.527978 19109544
30. GW Petty RD Brown Jr JP Whisnant JD Sicks WM O'Fallon DO Wiebers 1999 Ischemic stroke subtypes: a population-based study of incidence and risk factors Stroke 30 2513 2516 1:STN:280:DC%2BD3c%2FltFektQ%3D%3D 10582970
31. OY Bang JL Saver DS Liebeskind S Pineda B Ovbiagele 2008 Association of serum lipid indices with large artery atherosclerotic stroke Neurology 70 841 847 1:CAS:528:DC%2BD1cXislakt7o%3D 10.1212/01.wnl.0000294323.48661.a9 18160673 (Pubitemid 351367520)
32. K Matz C Tatschi K Sebek A Dachenhausen M Brainin 2004 Dyslipidemia, elevated LDL cholesterol and reduced nocturnal blood pressure dipping denote lacunar strokes occurring during nighttime [abstract] Eur J Neurol 11 742 748 1:STN:280:DC%2BD2crltlaqsg%3D%3D 10.1111/j.1468-1331.2004.00811.x 15525295 (Pubitemid 39556754)
33. S-E Megherbi C Milan D Minier G Couvreur GV Osseby K Tilling A Di Carlo D Inzitari CD Wolfe T Moreau M Giroud European BIOMED Study of Stroke Care Group 2003 Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project Stroke 34 688 694 10.1161/01.STR.0000057975.15221.40 12624292 (Pubitemid 36307394)
34. A Arboix A Rivas L García-Eroles L de Marcos J Massons M Oliveres 2005 Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-house mortality BMC Neurol 5 9 10.1186/1471-2377-5-9 15833108 (Pubitemid 41418218)
35. National Stroke Association. Recurrent stroke prevention. http://www.stroke.org/site/DocServer/Recurrent.pdf?docID=961. Accessed 31 Jul 2009
36. GW Petty RD Brown Jr JP Whisnant JD Sicks WM O'Fallon DO Wiebers 2000 Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence Stroke 31 1062 1068 1:STN:280:DC%2BD3c3lvFOmtw%3D%3D 10797166
37. JK Lovett AJ Coull PM Rothwell 2004 Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies Neurology 62 569 573 1:STN:280:DC%2BD2c%2FptFOgsg%3D%3D 14981172
38. JM Tobias B Azarbal 2005 Does patent foramen ovale promote cryptogenic stroke and migraine headache? Curr Issues Cardiol 32 362 365
39. S Homma RL Sacco MR DiTullio RR Sciacca JP Mohr for the PFO in Cryptogenic Stroke Study (PICSS) Investigators 2002 Effect of medical treatment in stroke patients with patent foramen ovale: patent foreman ovale in cryptogenic stroke study Circulation 105 2625 2631 10.1161/01.CIR.0000017498. 88393.44 12045168 (Pubitemid 34596039)
40. MS Dhamoon RR Sciacca T Rundek RL Sacco MS Elkind 2006 Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study Neurology 66 641 646 1:STN:280:DC%2BD287ks1Srtw%3D%3D 10.1212/01.wnl.0000201253. 93811.f6 16534100 (Pubitemid 43739815)
41. AM Basile A Di Carlo M Lamassa M Baldereschi G Carlucci D Consoli CD Wolfe M Giroud D Inzitari European BIOMED Study of Stroke Care Group 2008 Selective risk factors profiles and outcomes among patients with stroke and history of prior myocardial infarction J Neurol Sci 264 87 92 10.1016/j.jns.2007.07.025 17825846 (Pubitemid 350184077)
42. CP Warlow 1998 Epidemiology of stroke Lancet 352 S3 1 4 10.1016/S0140-6736(98)90086-1
43. A Arakelyan J Petrkova Z Hermanova A Boyajyan J Lukl M Petrek 2005 Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction Mediators Inflamm 2005 3 175 179 1:CAS:528:DC%2BD28XjsFOkurs%3D 10.1155/MI.2005.175 16106105 (Pubitemid 41381527)
44. M Fisher E Folland 2008 Acute ischemic coronary artery disease and ischemic stroke: similarities and differences Am J Ther 15 137 149 10.1097/MJT.0b013e31816a61bb 18356634 (Pubitemid 351459554)
45. SE Strauss SR Majumdar McAlister 2002 New evidence for stroke prevention: scientific review JAMA 288 1388 1395 10.1001/jama.288.11.1388
46. European Atrial Fibrillation Trial Study Group 1993 Secondary prevention in no-rheumatic atrial fibrillation after transient ischemic attack or minor stroke Lancet 342 1255 1262
47. ACTIVE Writing Group of the ACTIVE Investigators SJ Connolly J Progue RG Hart M Pfeffer S Hohnloser S Chloravicius M Pfeffer S Hohnloser S Yusuf 2006 Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Active fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W) Lancet 367 1903 1912 1:CAS:528:DC%2BD28XlsFCrsLg%3D 10.1016/S0140-6736(06)68845-4 16765759 (Pubitemid 43842067)
48. PT Akins HA Feldman RG Zoble D Newman SG Spitzer HC Diener, et al. 2007 Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials Stroke 38 3 874 880 1:CAS:528:DC%2BD2sXhslygtbc%3D 10.1161/01.STR.0000258004.64840.0b 17255547 (Pubitemid 46568446)
49. SJ Connolly S Yusuf J Camm the Active investigators study group 2009 Effect of clopidogrel added to aspirin in patients with atrial fibrillation (ACTIVE A) N Engl J Med 360 2066 2078 10.1056/NEJMoa0901301 19336502
50. SJ Connolly MD Ezekowitz S Yusuf the RE-LY Investigators 2009 Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139 1151 1:CAS:528:DC%2BD1MXhtFOjsLnN 10.1056/NEJMoa0905561 19717844
51. Diener HC, Connolly S, Ezekowitz MD et al. (2010) Dabigatran compared to warfarin in patients with atrial fibrillation and prior TIA or stroke: results of RE-LY. In: American Stroke Association International Stroke conference 2010, February 26, 2010, San Antonio, TX, USA, Abstract 195
52. SR Messé IE Silverman JR Kizer S Homma C Zahn G Gronseth SE Kasner Quality Standards Subcommittee of the American Academy of Neurology 2004 Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 62 1042 1050 15078999 (Pubitemid 38456495)
53. F Dentali JD Douketis W Lim M Crowther 2007 Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials Arch Intern Med 167 117 124 1:CAS:528:DC%2BD2sXhvFKms7w%3D 10.1001/archinte.167.2.117 17242311 (Pubitemid 46148058)
54. JP Mohr JLP Thompson RM Lazar B Levin RL Sacco KL Furie JP Kistler GW Albers LC Pettigrew HP Adams Jr CM Jackson P Pullicino Warfarin-Aspirin Recurrent Stroke Study Group 2001 A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke N Engl J Med 345 1444 1451 1:CAS:528:DC%2BD3MXovVaqsrc%3D 10.1056/NEJMoa011258 11794192
55. F Catella-Lawson MP Reilly SC Kapoor AJ Cucchiara S DeMarco B Tournier SN Vyas GA FitzGerald 2001 Cyclooxygenase inhibitors and the antiplatelet effects of aspirin N Engl J Med 345 1809 1817 1:CAS:528:DC%2BD38Xltl2juw%3D%3D 10.1056/NEJMoa003199 11752357
56. N Vartiainem G Goldsteins V Keksa-Golsteine PH Chan J Koistinnaho 2003 Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage Stroke 34 752 757 10.1161/01.STR.0000057813.31798.1F (Pubitemid 36307406)
57. Antiplatelet Trialists' Collaboration 2002 Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients BMJ 324 71 86 10.1136/bmj.324.7329. 71
58. AL Frelinger III AD Michelson 2005 Clopidogrel: linking evaluation of platelet response variability to mechanism of action J Am Coll Cardiol 46 646 647 10.1016/j.jacc.2005.05.039 16098429 (Pubitemid 41132691)
59. CAPRIE Steering Committee 1996 A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1329 1339 10.1016/S0140-6736(96)09457-3 (Pubitemid 26383772)
60. S Yusuf F Zhao SR Mehta S Chloravicius G Tognoni KK Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators 2001 Clopidogrel in unstable angina to prevent recurrent events (CURE) trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494 502 1:CAS:528:DC%2BD3MXms1arsrY%3D 10.1056/NEJMoa010746 11519503 (Pubitemid 32758501)
61. MS Sabatine CP Cannon CM Gibson JL López-Sendón G Montalescot P Theroux MJ Claeys F Cools KA Hill AM Skene CH McCabe E Braunwald CLARITY-TIMI 28 Investigators 2005 Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 1179 1189 1:CAS:528:DC%2BD2MXisFShsbY%3D 10.1056/NEJMoa050522 15758000 (Pubitemid 40397259)
62. ZM Chen LX Jiang YP Chen JX Xie HC Pan R Peto R Collins LS Liu COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group 2005 Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial Lancet 366 1607 1621 1:STN:280:DC%2BD2MrptlKmtQ%3D%3D 10.1016/S0140-6736(05)67660-X 16271642 (Pubitemid 41552416)
63. HC Diener J Bogousslavsky LM Brass C Cimminiello L Csiba M Kaste D Leys J Matias-Guiu HJ Rupprecht MATCH investigators 2004 Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial Lancet 364 331 337 1:CAS:528:DC%2BD2cXmtVSktbs%3D 10.1016/S0140-6736(04)16721-4 15276392 (Pubitemid 38970009)
64. DL Bhatt KA Fox W Hacke PB Berger HR Black WE Boden P Cacoub EA Cohen MA Creager JD Easton MD Flather SM Haffner CW Hamm GJ Hankey SC Johnston KH Mak JL Mas G Montalescot TA Pearson PG Steg SR Steinhubl MA Weber DM Brennan L Fabry-Ribaudo J Booth EJ Topol CHARISMA Investigators 2006 Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 1706 1717 1:CAS:528:DC%2BD28Xjs12gsLk%3D 10.1056/NEJMoa060989 16531616
65. DL Bhatt MD Flather W Hacke PB Berger HR Black WE Boden P Cacoub EA Cohen MA Creager JD Easton CW Hamm GJ Hankey SC Johnston KH Mak JL Mas G Montalescot TA Pearson PG Steg SR Steinhubl MA Weber DM Brennan L Fabry-Ribaudo T Hu Ej Topol KA Fox CHARISMA Investigators 2007 Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial J Am Coll Cardiol 49 1982 1988 10.1016/j.jacc.2007.03.025 17498584 (Pubitemid 46694290)
66. AS Weyrich EJ Skalabrin LW Kraiss 2009 Targeting the inflammatory response in secondary stroke prevention: a role for combing aspirin and extended-release dipyridamole Am J Ther 16 164 170 10.1097/MJT.0b013e31814b17bf 19300042
67. HC Diener L Cunha C Forbes J Sivenius P Smets A Lowenthal 1996 European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1 13 1:CAS:528: DyaK2sXisFOktQ%3D%3D 10.1016/S0022-510X(96)00308-5 8981292 (Pubitemid 26402780)
68. ESPRIT Study Group PH Halkes J van Gijn LJ Kappelle PJ Koudstaal A Algra 2006 Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial Lancet 367 1665 1673 1:STN:280:DC%2BD283osVejtg%3D%3D 10.1016/S0140-6736(06)68734-5 16714187 [published correction appears in Lancet 2007; 369:274] (Pubitemid 43728258)
69. RL Sacco HC Diener S Yusuf D Cotton S Ounpuu WA Lawton Y Palesch RH Martin GW Albers P Bath N Bornstein BP Chan ST Chen L Cunha B Dahlöf J De Keyser GA Donnan C Estol P Gorelick V Gu K Hermansson L Hilbrich M Kaste C Lu T Machnig P Pais R Roberts V Skvortsova P Teal D Toni C Vandermaelen T Voigt M Weber BW Yoon PRoFESS Study Group 2008 Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke N Engl J Med 359 1238 1251 1:CAS:528:DC%2BD1cXhtFGjurjF 10.1056/NEJMoa0805002 18753638
70. U.S. National Institutes of Health. Warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. http://clinicaltrials.gov/ct2/show/ NCT00041938. Accessed 12 Aug 2009
71. U.S. National Institutes of Health. Aortic arch related cerebral hazard trial (ARCH). http://clinicaltrials.gov/ct2/show/NCT00235248. Accessed 12 Aug 2009
72. U.S. National Institutes of Health. Secondary prevention of small subcortical strokes (SPS3) trial. http://www.clinicaltrials.gov/ct/show/ NCT00059306. Accessed 12 Aug 2009
73. U.S. National Institutes of Health. Combination of clopidogrel and aspirin for prevention of early recurrence in acute atherothrombotic stroke (COMPRESS). http://clinicaltrials.gov/ct2/show/NCT00814268. Accessed 12 Aug 2009
74. U.S. National Institutes of Health. Clinicaltrial.gov. Platelet-Oriented Inhibition in New Transient Ischemic Attack (POINT) trial. http:// clinicaltrials.gov/ct2/show/NCT00991029. Accessed 19 Nov 2009
75. Stroke Trials Registry at University of Washington. RESPECT: randomized evaluation of recurrent stroke comparing PFO closure to established current standard of care treatment. http://www.strokecenter.org/trials/TrialDetail.aspx? tid=482. Accessed 12 Aug 2009
76. U.S. National Institutes of Health. Clinicaltrials.gov. Closure I. http://www.clinicaltrials.gov/ct2/show/NCT00201461?term=closure+i&rank=1. Accessed 19 Nov 2009